Quick Answer
Tenon Medical, Inc. reported R&D Expense of $2.15 million for fiscal year 2025.
Tenon Medical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.15M | -17.4% |
| 2024 | $2.60M | -17.7% |
| 2023 | $3.16M | +11.8% |
| 2022 | $2.83M | +64.6% |
| 2021 | $1.72M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $428.0K | -34.9% | -14.9% |
| June 30, 2025 | $503.0K | -29.0% | -27.2% |
| March 31, 2025 | $691.0K | +3.3% | +5.2% |
| September 30, 2024 | $657.0K | -10.9% | -7.2% |
| June 30, 2024 | $708.0K | -21.4% | +5.8% |
| March 31, 2024 | $669.0K | -19.8% | -9.2% |
| September 30, 2023 | $737.0K | -7.5% | -18.2% |
| June 30, 2023 | $901.0K | +37.1% | +8.0% |
- Tenon Medical, Inc. showed a decrease of -17.4% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2025 period, Tenon Medical, Inc.’s r&d expense has grown by 25.1% (from $1.72 million to $2.15 million).
- The most recent figure is from Tenon Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: